HomeInsightsMarket Capitalization

Market Capitalization of Parmax Pharma Ltd

Market Capitalization of Parmax Pharma Ltd

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

2.8 K

stocks traded

Last Updated time: 13 Oct 15:30 PM

Image

Parmax Pharma Ltd

NSE: PARMAXPHARMA

MARKETCAP

14.06 crore

Last updated: 11 Oct 24

Key Highlights

  • The Market Cap of Parmax Pharma Ltd is ₹ 14.06 crore as of 11 Oct 24.
  • The Market Cap of Parmax Pharma Ltd changed from ₹ 13.28 crore on March 2019 to ₹ 10.66 crore on March 2024 . This represents a CAGR of -5.35% over 4 years. .
  • The Latest Trading Price of Parmax Pharma Ltd is ₹ 37.57 as of 11 Oct 15:30.

Historical Market Cap of Parmax Pharma Ltd

No data available

* All values are in crore

Company Fundamentals for Parmax Pharma Ltd

No data available

Image

Parmax Pharma Ltd

NSE: PARMAXPHARMA

PRICE

37.57

1.78 (4.97%)

stock direction

Last updated: 11 Oct 15:30

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Parmax Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
11 Oct 202437.57
10 Oct 202435.79
09 Oct 202437.67
08 Oct 202439.65
07 Oct 202441.73
04 Oct 202443.92
03 Oct 202442.09
01 Oct 202444.3
30 Sep 202446.63
27 Sep 202449.08

BlinkX Score for Parmax Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Parmax Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Parmax Pharma Ltd014
Sun Pharmaceuticals Industries Ltd434,56,342
Divis Laboratories Ltd971,63,028
Cipla Ltd291,28,827
Torrent Pharmaceuticals Ltd701,18,373
Mankind Pharma Ltd571,11,956

Key Valuation Metric of Parmax Pharma Ltd

No data available

Historical P/E Ratio of Parmax Pharma Ltd

No data available

* All values are in %

Historical Revenue of Parmax Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Parmax Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Parmax Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Parmax Pharma Ltd

No data available

* All values are in %

About Parmax Pharma Ltd

  • Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
  • The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
  • The Company then discontinued their business activities for few years due to various reasons.
  • Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

Parmax Pharma Ltd News Hub

News

Parmax Pharma to conduct AGM

Parmax Pharma announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

18 Sep 202416:46

News

Parmax Pharma to declare Quarterly Result

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 August 20...

Read more

09 Aug 202414:53

News

Parmax Pharma revises board meeting date

Parmax Pharma has revised the meeting of the Board of Directors which was scheduled to be ...

Read more

29 May 202412:10

News

Parmax Pharma schedules board meeting

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2024 ...

Read more

24 May 202412:53

News

Parmax Pharma to hold board meeting

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 February ...

Read more

09 Feb 202416:10

News

Parmax Pharma announces board meeting date

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 10 November ...

Read more

07 Nov 202314:09

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Parmax Pharma Ltd

What is the market cap of Parmax Pharma Ltd?

As of October 13, 2024, Parmax Pharma Ltd has a market capitalization of ₹14.06, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Parmax Pharma Ltd's market capitalization?

Parmax Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Parmax Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Parmax Pharma Ltd's market capitalization change?

Parmax Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*